Clearmind Medicine joins Frontiers of Mental Health and Recovery Summit
CMND•Clearmind Medicine will attend the summit in Washington, D.C., the week of Nov. 10, 2026, where Chief of Global Impact Mary-Elizabeth Gifford will discuss CMND-100 and Phase II trial updates.
1. Summit appearance
Clearmind Medicine will attend the two-day Frontiers of Mental Health and Recovery Summit in Washington, D.C., the week of Nov. 10, 2026. Chief of Global Impact Mary-Elizabeth Gifford will discuss CMND-100 for alcohol use disorder, including Phase II trial updates. BrainFutures convened the summit to focus on preparing healthcare systems for psychedelic therapies.
